Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 May;34(5):580–583. doi: 10.1136/gut.34.5.580

Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

A S Taha 1, R I Russell 1
PMCID: PMC1374170  PMID: 8504954

Full text

PDF
580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apel I., Jacobs E., Kist M., Bredt W. Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Apr;268(2):271–276. doi: 10.1016/s0176-6724(88)80012-9. [DOI] [PubMed] [Google Scholar]
  2. Arakawa T., Nakamura H., Chono S., Satoh H., Fukuda T., Saeki Y., Kobayashi K. Absence of effect of 16,16-dimethyl prostaglandin E2 on reduction of gastric mucosal blood flow caused by indomethacin in rats. Dig Dis Sci. 1989 Sep;34(9):1369–1373. doi: 10.1007/BF01538071. [DOI] [PubMed] [Google Scholar]
  3. Baskin W. N., Ivey K. J., Krause W. J., Jeffrey G. E., Gemmell R. T. Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference. Ann Intern Med. 1976 Sep;85(3):299–303. doi: 10.7326/0003-4819-85-3-299. [DOI] [PubMed] [Google Scholar]
  4. Baum C., Kennedy D. L., Forbes M. B. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1985 Jun;28(6):686–692. doi: 10.1002/art.1780280613. [DOI] [PubMed] [Google Scholar]
  5. Bjarnason I., Hayllar J., Smethurst P., Price A., Gumpel M. J. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992 Sep;33(9):1204–1208. doi: 10.1136/gut.33.9.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caselli M., Pazzi P., LaCorte R., Aleotti A., Trevisani L., Stabellini G. Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion. 1989;44(2):101–104. doi: 10.1159/000199898. [DOI] [PubMed] [Google Scholar]
  7. Cave D. R., Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet. 1989 Jul 22;2(8656):187–189. doi: 10.1016/s0140-6736(89)90372-3. [DOI] [PubMed] [Google Scholar]
  8. Chittajallu R. S., Dorrian C. A., Neithercut W. D., Dahill S., McColl K. E. Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? Gut. 1991 Nov;32(11):1286–1290. doi: 10.1136/gut.32.11.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooke A. R. The role of the mucosal barrier in drug-induced gastric ulceration and erosions. Am J Dig Dis. 1976 Feb;21(2):155–164. doi: 10.1007/BF01072063. [DOI] [PubMed] [Google Scholar]
  10. Crabtree J. E., Mahony M. J., Taylor J. D., Heatley R. V., Littlewood J. M., Tompkins D. S. Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol. 1991 Sep;44(9):768–771. doi: 10.1136/jcp.44.9.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Crabtree J. E., Taylor J. D., Wyatt J. I., Heatley R. V., Shallcross T. M., Tompkins D. S., Rathbone B. J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991 Aug 10;338(8763):332–335. doi: 10.1016/0140-6736(91)90477-7. [DOI] [PubMed] [Google Scholar]
  12. Cryer B., Faust T. W., Goldschmiedt M., Redfern J. S., Lee E., Feldman M. Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relationships with demographics, environmental, and histological factors, including Helicobacter pylori. Am J Gastroenterol. 1992 Dec;87(12):1747–1754. [PubMed] [Google Scholar]
  13. Denizot Y., Sobhani I., Rambaud J. C., Lewin M., Thomas Y., Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut. 1990 Nov;31(11):1242–1245. doi: 10.1136/gut.31.11.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dixon M. F., O'Connor H. J., Axon A. T., King R. F., Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol. 1986 May;39(5):524–530. doi: 10.1136/jcp.39.5.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ehsanullah R. S., Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988 Oct 22;297(6655):1017–1021. doi: 10.1136/bmj.297.6655.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Feldman M., Colturi T. J. Effect of indomethacin on gastric acid and bicarbonate secretion in humans. Gastroenterology. 1984 Dec;87(6):1339–1343. [PubMed] [Google Scholar]
  17. Gana T. J., MacPherson B. R., Koo J. Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration. Ann Surg. 1988 Mar;207(3):327–334. doi: 10.1097/00000658-198803000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gerkens J. F., Shand D. G., Flexner C., Nies A. S., Oates J. A., Data J. L. Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther. 1977 Dec;203(3):646–652. [PubMed] [Google Scholar]
  19. Graham D. Y. Helicobacter pylori and the endoscopist: whether to diagnose. Gastrointest Endosc. 1991 Sep-Oct;37(5):577–579. doi: 10.1016/s0016-5107(91)70838-9. [DOI] [PubMed] [Google Scholar]
  20. Graham D. Y., Klein P. D., Opekun A. R., Boutton T. W. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis. 1988 Apr;157(4):777–780. doi: 10.1093/infdis/157.4.777. [DOI] [PubMed] [Google Scholar]
  21. Graham D. Y., Lidsky M. D., Cox A. M., Evans D. J., Jr, Evans D. G., Alpert L., Klein P. D., Sessoms S. L., Michaletz P. A., Saeed Z. A. Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991 Jun;100(6):1653–1657. doi: 10.1016/0016-5085(91)90665-8. [DOI] [PubMed] [Google Scholar]
  22. Hawkey C. J. Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut. 1986 Dec;27(12):1484–1492. doi: 10.1136/gut.27.12.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Konturek S. J., Bilski J., Kwiecien N., Obtuløwicz W., Kopp B., Oleksy J. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism. Gut. 1987 Dec;28(12):1557–1563. doi: 10.1136/gut.28.12.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Konturek S. J., Kwiecień N., Obtułowicz W., Hebzda Z., Oleksy J. Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss, and prostaglandin formation in humans. Scand J Gastroenterol. 1988 Sep;23(7):861–866. doi: 10.3109/00365528809090774. [DOI] [PubMed] [Google Scholar]
  25. Lanza F. L., Evans D. G., Graham D. Y. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol. 1991 Jun;86(6):735–737. [PubMed] [Google Scholar]
  26. Levine R. A., Nandi J., King R. L. Nonsalicylate nonsteroidal antiinflammatory drugs augment prestimulated acid secretion in rabbit parietal cells. Investigation of the mechanisms of action. Gastroenterology. 1991 Sep;101(3):756–765. doi: 10.1016/0016-5085(91)90536-t. [DOI] [PubMed] [Google Scholar]
  27. Levine R. A., Schwartzel E. H. Effect of indomethacin on basal and histamine stimulated human gastric acid secretion. Gut. 1984 Jul;25(7):718–722. doi: 10.1136/gut.25.7.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Loeb D. S., Talley N. J., Ahlquist D. A., Carpenter H. A., Zinsmeister A. R. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun;102(6):1899–1905. doi: 10.1016/0016-5085(92)90311-l. [DOI] [PubMed] [Google Scholar]
  29. MENGUY R., MASTERS Y. F. EFFECTS OF ASPIRIN ON GASTRIC MUCOUS SECRETION. Surg Gynecol Obstet. 1965 Jan;120:92–98. [PubMed] [Google Scholar]
  30. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  31. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  32. Menguy R., Desbaillets L. Role of inhibition of gastric mucous secretion in the phenomenon of gastric mucosal injury by indomethacin. Am J Dig Dis. 1967 Sep;12(9):862–866. doi: 10.1007/BF02236444. [DOI] [PubMed] [Google Scholar]
  33. Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol. 1987 Mar;82(3):192–199. [PubMed] [Google Scholar]
  34. Newell D. G. Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. J Gen Microbiol. 1987 Jan;133(1):163–170. doi: 10.1099/00221287-133-1-163. [DOI] [PubMed] [Google Scholar]
  35. Redfern J. S., Lee E., Feldman M. Effect of indomethacin on gastric mucosal prostaglandins in humans. Correlation with mucosal damage. Gastroenterology. 1987 Apr;92(4):969–977. doi: 10.1016/0016-5085(87)90972-3. [DOI] [PubMed] [Google Scholar]
  36. Rees W. D., Gibbons L. C., Turnberg L. A. Effects of non-steroidal anti-inflammatory drugs and prostaglandins on alkali secretion by rabbit gastric fundus in vitro. Gut. 1983 Sep;24(9):784–789. doi: 10.1136/gut.24.9.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Robert A., Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins. 1977 Aug;14(2):333–341. doi: 10.1016/0090-6980(77)90178-2. [DOI] [PubMed] [Google Scholar]
  38. Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
  39. Sarosiek J., Mizuta K., Slomiany A., Slomiany B. L. Effect of acetylsalicylic acid on gastric mucin viscosity, permeability to hydrogen ion, and susceptibility to pepsin. Biochem Pharmacol. 1986 Dec 1;35(23):4291–4295. doi: 10.1016/0006-2952(86)90708-2. [DOI] [PubMed] [Google Scholar]
  40. Sarosiek J., Slomiany A., Slomiany B. L. Evidence for weakening of gastric mucus integrity by Campylobacter pylori. Scand J Gastroenterol. 1988 Jun;23(5):585–590. doi: 10.3109/00365528809093916. [DOI] [PubMed] [Google Scholar]
  41. Shallcross T. M., Rathbone B. J., Wyatt J. I., Heatley R. V. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 1990 Oct;4(5):515–522. doi: 10.1111/j.1365-2036.1990.tb00498.x. [DOI] [PubMed] [Google Scholar]
  42. Skander M. P., Ryan F. P. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. BMJ. 1988 Oct 1;297(6652):833–834. doi: 10.1136/bmj.297.6652.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Smith J. T., Pounder R. E., Nwokolo C. U., Lanzon-Miller S., Evans D. G., Graham D. Y., Evans D. J., Jr Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut. 1990 May;31(5):522–525. doi: 10.1136/gut.31.5.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sobala G. M., Crabtree J. E., Pentith J. A., Rathbone B. J., Shallcross T. M., Wyatt J. I., Dixon M. F., Heatley R. V., Axon A. T. Screening dyspepsia by serology to Helicobacter pylori. Lancet. 1991 Jul 13;338(8759):94–96. doi: 10.1016/0140-6736(91)90085-4. [DOI] [PubMed] [Google Scholar]
  45. Sobala G. M., King R. F., Axon A. T., Dixon M. F. Reflux gastritis in the intact stomach. J Clin Pathol. 1990 Apr;43(4):303–306. doi: 10.1136/jcp.43.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Taha A. S., Angerson W., Nakshabendi I., Beekman H., Morran C., Sturrock R. D., Russell R. I. Gastric and duodenal mucosal blood flow in patients receiving non-steroidal anti-inflammatory drugs--influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther. 1993 Feb;7(1):41–45. doi: 10.1111/j.1365-2036.1993.tb00067.x. [DOI] [PubMed] [Google Scholar]
  47. Taha A. S., Boothman P., Holland P., McKinlay A., Upadhyay R., Kelly R. W., Lee F., Russell R. I. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol. 1990 Jan;85(1):47–50. [PubMed] [Google Scholar]
  48. Taha A. S., Capell H. A., Sturrock R. D., Russell R. I. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol. 1991 Nov;86(11):1588–1591. [PubMed] [Google Scholar]
  49. Taha A. S., Fraser W. D., Kelly R. W., Gemmell C. G., Lee F. D., Russell R. I. Inhibition of human gastric cyclic AMP production by Helicobacter pylori protein--possible involvement of mucosal prostaglandin E2. Aliment Pharmacol Ther. 1991 Aug;5(4):379–389. doi: 10.1111/j.1365-2036.1991.tb00041.x. [DOI] [PubMed] [Google Scholar]
  50. Taha A. S., Kelly R. W., Gemmell C. G., Lee F. D., Russell R. I. The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro. Aliment Pharmacol Ther. 1990 Jun;4(3):265–273. doi: 10.1111/j.1365-2036.1990.tb00471.x. [DOI] [PubMed] [Google Scholar]
  51. Taha A. S., McLaughlin S., Holland P. J., Kelly R. W., Sturrock R. D., Russell R. I. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann Rheum Dis. 1990 Jun;49(6):354–358. doi: 10.1136/ard.49.6.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Taha A. S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol. 1992 Feb;45(2):135–139. doi: 10.1136/jcp.45.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Taha A. S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol. 1992 Feb;45(2):135–139. doi: 10.1136/jcp.45.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Taha A. S., Reid J., Boothmann P., Gemmell C. G., Lee F. D., Sturrock R. D., Russell R. I. Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut. 1993 Apr;34(4):461–465. doi: 10.1136/gut.34.4.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Trevethick M. A., Clayton N. M., Strong P., Harman I. W. Do infiltrating neutrophils contribute to the pathogenesis of indomethacin induced ulceration of the rat gastric antrum? Gut. 1993 Feb;34(2):156–160. doi: 10.1136/gut.34.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wagner S., Gladziwa U., Haruma K., Varrentrapp M., Gebel M. Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut. 1992 Aug;33(8):1024–1028. doi: 10.1136/gut.33.8.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wallace J. L., Keenan C. M., Granger D. N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990 Sep;259(3 Pt 1):G462–G467. doi: 10.1152/ajpgi.1990.259.3.G462. [DOI] [PubMed] [Google Scholar]
  58. Walt R., Katschinski B., Logan R., Ashley J., Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet. 1986 Mar 1;1(8479):489–492. doi: 10.1016/s0140-6736(86)92940-5. [DOI] [PubMed] [Google Scholar]
  59. de Witte T. J., Geerdink P. J., Lamers C. B., Boerbooms A. M., van der Korst J. K. Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis. 1979 Feb;38(1):14–17. doi: 10.1136/ard.38.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. von Wulffen H., Grote H. J., Gatermann S., Löning T., Berger B., Buhl C. Immunoblot analysis of immune response to Campylobacter pylori and its clinical associations. J Clin Pathol. 1988 Jun;41(6):653–659. doi: 10.1136/jcp.41.6.653. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES